Sheila Davis, DNP, ANP-BC, FAAN

CEO, Partners In Health

 Dr. Sheila Davis is the CEO of Partners In Health (PIH). Prior to this, Dr. Davis served as the Chief of Clinical Operations and Chief Nursing Officer at PIH, where she oversaw nursing efforts as well as supply chain, medical informatics, laboratory, infrastructure, and quality improvement activities. Previously, she served as the Chief of Ebola Response as she led PIH’s response efforts during the 2014 West Africa epidemic. She has been a nursing leader in the field of HIV/AIDS since the mid-1980s and served on the National Board of the Association of Nurses AIDS Care (ANAC).  She entered the global health arena in 1999 responding to the global HIV pandemic working in a number of countries. She was the co-founder of a small NGO that worked in South Africa and Boston from 2004-2010 on health projects, including a rural village nurse clinic. Dr. Davis is a frequent national speaker on global health and clinical topics including HIV/AIDS, the Ebola epidemic, leadership in public health, and the role of nursing in human rights. 


Dr. Davis received her BSN degree from Northeastern University in 1988, her Masters in Nursing degree as an Adult Nurse Practitioner in 1997 and her Doctorate in Nursing Practice with a concentration in global health in 2008. Both of her graduate degrees are from the MGH Institute of Health Professions.  Dr. Davis was a faculty member at the School of Nursing at the MGH Institute of Health Professions for 4 years and an Adult Nurse Practitioner at the MGH Infectious Diseases outpatient practice for over 15 years. Currently she is Adjunct faculty at the UCSF School of Nursing and an affiliate member of Adriadne Labs. She was inducted as Fellow in the American Academy of Nursing in 2008 and in 2009 was inducted as a member of the inaugural class of 12 Carl Wilken’s Fellows working on anti-genocide global efforts as part of the Genocide Intervention Network. She recently completed a Robert Wood Johnson Executive Nurse Fellowship as part of the 2012-2015 cohort.